Roche Alzheimer’s Early Detection Tests Get FDA Green Light
In this month’s diagnostics pipeline report, Roche gets clearance for two new Alzheimer’s early detection tests.
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article